Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protalix BioTherapeutics

1.45
-0.0500-3.33%
Post-market: 1.450.00000.00%16:09 EDT
Volume:514.63K
Turnover:766.20K
Market Cap:115.43M
PE:30.11
High:1.52
Open:1.51
Low:1.45
Close:1.50
Loading ...

Barclays Sticks to Their Hold Rating for PLUXEE N.V. (PLX)

TIPRANKS
·
10 Jul

J.P. Morgan Sticks to Its Hold Rating for PLUXEE N.V. (PLX)

TIPRANKS
·
07 Jul

Bernstein Sticks to Its Buy Rating for PLUXEE N.V. (PLX)

TIPRANKS
·
05 Jul

Citi Sticks to Their Buy Rating for PLUXEE N.V. (PLX)

TIPRANKS
·
04 Jul

UBS Keeps Their Hold Rating on PLUXEE N.V. (PLX)

TIPRANKS
·
04 Jul

Barclays Sticks to Its Hold Rating for PLUXEE N.V. (PLX)

TIPRANKS
·
04 Jul

PLUXEE N.V. (PLX) Receives a Buy from Kepler Capital

TIPRANKS
·
04 Jul

Protalix BioTherapeutics Inc. Files Initial Statement of Beneficial Ownership for Director Elze Christian

Reuters
·
04 Jul

Protalix BioTherapeutics Joins Russell 3000 and 2000 Indexes

Reuters
·
30 Jun

Protalix BioTherapeutics Inc. Convened Annual Stockholders Meeting

Reuters
·
27 Jun

Barclays Keeps Their Hold Rating on PLUXEE N.V. (PLX)

TIPRANKS
·
09 Jun

Protalix BioTherapeutics Inc. Unveils Corporate Presentation Highlighting Expansion in Rare Disease Space

Reuters
·
14 May

Protalix BioTherapeutics Inc. to Present at H.C. Wainwright BioConnect Investor Conference in NYC

Reuters
·
14 May

Protalix BioTherapeutics Earnings Call: Growth Amid Challenges

TIPRANKS
·
10 May

Protalix BioTherapeutics Q1 EPS $(0.05) Misses $0.03 Estimate, Sales $10.11M Miss $21.60M Estimate

Benzinga
·
09 May

Press Release: Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results

Dow Jones
·
09 May

PLUXEE N.V. (PLX) Receives a Buy from Citi

TIPRANKS
·
06 May

Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025

PR Newswire
·
05 May

Protalix files $100M mixed securities shelf

TIPRANKS
·
29 Apr

Top Penny Stocks To Watch In April 2025

Simply Wall St.
·
25 Apr